Updated Apr 17, 2018CLOSED
Offered by African Academy of Sciences, Bill & Melinda Gates Foundation and New Partnership for Africa's Development as part of Alliance for Accelerating Excellence in Science in Africa and Grand Challenges Africa
|Criteria: Label||Criteria: Description||Amount Per Prize|
|Grant Category||Seed Grants||Up to $100,000|
|Grant Category||Innovation Transition Grants||Up to $250,000|
|Stage||Stage 2: Research & Development, Stage 3: Proof of Concept and Stage 4: Transition to Scale|
Specifically, we seek projects that propose innovation in the following areas:Data sources: Pilot tests of new sources of data, particularly those that would bring together different research communities for new perspectives on the problem
|Management Team||African investigators are invited to apply, with the support of the primary organization where they are affiliated, and where the major programme of work will be undertaken.|
|Past Impact Evaluation|
Seed grants (funded at up to $100,000 USD) do not require extensive preliminary data and are meant to provide an opportunity to test particularly bold ideas, including applying approaches from outside the field or that bridge fields. New approaches could be piloted as additions to ongoing funded projects. The application process entails submission of an online application succinctly describing the new approach and how it will be tested.
Full grants – Open to South African Nationals only (funded at up to $250,000 USD) do require substantial preliminary data and are meant to provide an opportunity to refine and rigorously test approaches, including those that have previously shown promise in controlled or limited settings.
|Other||We will NOT consider funding for:|
-Proposals to develop diagnostic devices and technologies or for drug discovery. Although diagnostic devices and new drugs are potentially critical to AMR solutions, these areas are not unique to AMR challenges and should therefore be advanced more comprehensively against a broader landscape of possible needs and solutions. Thus, while excluded here, they may be part of a future request for proposals.
-Proposals without a clear application to surveillance or facilitating the development of new evidence describing the global burden of AMR
-Proposals seeking to apply existing tools in ways that do not transform our understanding of the global emergence or spread of AMR
-Incremental improvements to conventional solutions or typical disease surveillance. We will not consider local surveillance programs or projects or small improvements in surveillance, e.g., use of mobile data collection, automation of traditional processes, or improving access to existing tools or technologies.
-Proposals that simply expand the availability of primary data without a clear link to informing our understanding of global AMR epidemiology
-Applications proposing basic research
-Ideas not directly relevant to low- and middle-income contexts
-Genomic and other laboratory-based approaches that lack a clear application to AMR surveillance or epidemiology
-Ideas focused on quantifying resistance in animal or livestock populations or in environmental samples without a direct linkage to how data would impact public health practice
-Proposals involving clinical trials in human volunteers or patients (note: use of existing datasets or other outputs from clinical trials may be considered, as long as the proposed approach is feasible within the time and financial envelopes provided).
This request for proposals seeks to encourage scientific collaborations between African researchers, and between different organizations across the continent. We therefore seek to encourage data sharing between individually funded projects. We expect that such sharing will help to ensure that the goals of the innovative approaches in individual projects are ultimately integrated with each other. Furthermore, we expect that sharing experimental methods, data, and resources will ultimately improve the ability to compare and validate local research findings and to develop innovations, interventions and products that can have impact at a greater scale. The reviewers to this call will evaluate how well applications address these requirements. Collaborative efforts include:
-Cohort harmonization: when collaborating with projects with existing cohorts or establishing new cohorts, investigators will be expected to participate, whenever possible, in cohort harmonization. Study sites will be expected to develop and follow standard operating procedures and quality control protocols for specimen collections and participate in the establishment of a minimum common set of data and specimens to be collected across the program.
-Data sharing: Projects will submit a data sharing plan that is equitable, ethical, and efficient.